Lack of pharmacokinetic interaction between cimetidine and tirilazad mesylate. 1994

J C Fleishaker, and L K Hulst, and G R Peters
Clinical Phamacokinetics Unit, Upjohn Company, Kalamazoo, Michigan 49007.

UI MeSH Term Description Entries
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011281 Pregnatrienes Pregnane derivatives containing three double bonds in the ring structures.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J C Fleishaker, and L K Hulst, and G R Peters
September 1985, Clinical pharmacology and therapeutics,
J C Fleishaker, and L K Hulst, and G R Peters
October 1996, British journal of clinical pharmacology,
J C Fleishaker, and L K Hulst, and G R Peters
October 2005, Antimicrobial agents and chemotherapy,
J C Fleishaker, and L K Hulst, and G R Peters
October 1983, Acta neurologica Scandinavica,
J C Fleishaker, and L K Hulst, and G R Peters
January 1987, Pharmacotherapy,
J C Fleishaker, and L K Hulst, and G R Peters
September 1985, Clinical pharmacology and therapeutics,
J C Fleishaker, and L K Hulst, and G R Peters
August 1995, British journal of clinical pharmacology,
J C Fleishaker, and L K Hulst, and G R Peters
January 1983, European journal of clinical pharmacology,
J C Fleishaker, and L K Hulst, and G R Peters
December 1993, Journal of veterinary pharmacology and therapeutics,
J C Fleishaker, and L K Hulst, and G R Peters
May 1997, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!